NHS
Southampton City Pharmaceutical Needs Assessment (PNA) document was approved at the public PCT Board meeting held
on 19th January 2011.
The
PNA was developed between February and November 2010. Public consultation was
undertaken between 9 September 2010 to 30 November 2010 and thanks go to everyone
who sent in a response. This final document reflects the outcomes of the
consultation.
The need to assess quality of service delivery and
ensure appropriate governance and monitoring systems are in place have been
identified as priorities through the PNA process. Development of specific
quality indicators as services are reviewed is proposed as a key action.
It is also proposed that early in 2011 progress
will be made in developing the Healthy Living Pharmacy concept. This was
highlighted in the recent Public Health White Paper: Healthy Lives, Healthy
People: Our Strategy for public health in England and will provide an
overarching framework for a range of pharmacy activity. The key recommendations
at the end of the PNA are outlined below:
1. Enhancing Quality, Governance and Systems
It is proposed that
pharmacy essential services provision is reviewed locally to maximise the role
and contribution of community pharmacy around the following:
(i)
Support for self care/minor ailments
(ii)
Signposting to other services
(iii)
Health promotion campaigns (up to 6 per year). To date only 3 campaigns per year have been
run and evaluation has been poor.
2. Service
Re-design
It is proposed that the
role and contribution of community pharmacy to service redesign is strengthened
by reviewing:
(i)
MUR provision.
(ii)
Existing enhanced Services: Smoking cessation services contribute less
than 10% of quitters to the local target and the service is not offered in all
priority neighbourhoods. There is scope
for extension of this service.
(iii)
Potential service provision through pharmacy for areas identified in
section 7 according to patient outcomes, cost effectiveness, capabilities and
existing provision by other services.
(iv)
Options for improved promotion of pharmacy services, e.g. through
provision of a ‘branding’ quality assurance scheme.
This will be aligned with
ongoing patient care pathway reviews using Map of Medicines, a nationally
developed tool incorporating best clinical practice guidelines and evidence
based medicine.
3. Operational Improvements
It is proposed that
operational improvements are progressed through:
(ii)
Development of electronic prescribing.
Some pharmacies have the technical capabilities required to manage
electronic prescribing and will be ready to go ‘live’ during 2011. Further work is required to manage this
process with GP practices.
(ii) Identification of training and support
needs for pharmacists and counter staff to provide the above.
For further information
please contact:
Sue Lawton Community
Pharmacy Development Manager
Tel: 023 8029 6916 email:
sue.lawton@nhs.net
